Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study.
Miller S, Jiang R, Schipper M, Fritsche LG, Strohbehn G, Wallace B, Brinzevich D, Falvello V, McMahon BH, Zamora-Resendiz R, Ramnath N, Dai X, Sankar K, Edwards DM, Allen SG, Yoo S, Crivelli S, Green MD, Bryant AK.
Miller S, et al. Among authors: brinzevich d.
Lancet Oncol. 2024 Dec;25(12):1666-1676. doi: 10.1016/S1470-2045(24)00528-X. Epub 2024 Nov 14.
Lancet Oncol. 2024.
PMID: 39551068